832 related articles for article (PubMed ID: 21981759)
21. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance.
Lee HJ; Kim DI; Kwak C; Ku JH; Moon KC
Urology; 2008 Sep; 72(3):603-7. PubMed ID: 18384848
[TBL] [Abstract][Full Text] [Related]
24. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
25. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
26. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
28. Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype.
Vilella-Arias SA; Rocha RM; da Costa WH; Zequi Sde C; Guimarães GC; Verjovski-Almeida S; Soares FA; Reis EM
Urology; 2013 Oct; 82(4):974.e1-7. PubMed ID: 23920448
[TBL] [Abstract][Full Text] [Related]
29. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.
Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W
Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma.
Lee HJ; Kim DI; Kang GH; Kwak C; Ku JH; Moon KC
Urology; 2009 Feb; 73(2):394-9. PubMed ID: 18849062
[TBL] [Abstract][Full Text] [Related]
33. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
34. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma.
Cai MY; Luo RZ; Li YH; Dong P; Zhang ZL; Zhou FJ; Chen JW; Yun JP; Zhang CZ; Cao Y
Biochem Biophys Res Commun; 2012 Oct; 426(4):636-42. PubMed ID: 22982674
[TBL] [Abstract][Full Text] [Related]
35. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
Kruck S; Hennenlotter J; Vogel U; Schilling D; Gakis G; Hevler J; Kuehs U; Stenzl A; Schwentner C
BJU Int; 2012 Feb; 109(4):634-8. PubMed ID: 21711439
[TBL] [Abstract][Full Text] [Related]
36. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
[TBL] [Abstract][Full Text] [Related]
37. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
[TBL] [Abstract][Full Text] [Related]
38. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
[TBL] [Abstract][Full Text] [Related]
39. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.
Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K
Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of p27Kip1 expression in bladder cancer.
Rabbani F; Koppie TM; Charytonowicz E; Drobnjak M; Bochner BH; Cordon-Cardo C
BJU Int; 2007 Aug; 100(2):259-63. PubMed ID: 17555476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
